CTOs on the Move

Erie Family Health Center

www.eriefamilyhealth.org

 
At Erie Family Health Centers, we believe health care is a right, not a privilege. Our mission is to provide accessible, affordable and high quality health care for those in need. Since 1957, when the Erie was first established as a volunteer clinic by doctors from Northwestern Memorial Hospital, it has been Erie`s mission to ensure that all Chicagoans have access to high quality, culturally sensitive, bilingual health care services — regardless of their ability to pay. Today, Erie serves over 74,000 patients annually at thirteen sites, including seven large primary health centers, five school-based health centers, a teen health center, ...
  • Number of Employees: 250-1000
  • Annual Revenue: $50-100 Million

Executives

Name Title Contact Details

Similar Companies

BioRealty

BioRealty, Inc. is a San Clemente, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

ACRIA

ACRIA is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Copper Queen Community Hospital

Copper Queen Community Hospital has a rich heritage, dating back to the 1880s when it operated as a part of the mining community, so important to the history of Bisbee.

Streamfeeder

Streamfeeder is a Minneapolis, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Relmada

Relmada Therapeutics (OTCQB: RLMD) is a clinical-stage, publicly traded specialty pharmaceutical company developing novel versions of proven drug products together with new chemical entities that potentially address areas of high unmet medical need in the treatment of chronic pain. Relmada has a diversified portfolio of four lead products at various stages of development including d-Methadone (REL-1017) its N-methyl-D-aspartate (NMDA) receptor antagonist for neuropathic pain; topical mepivacaine (REL-1021), its orphan drug designated topical formulation of the local anesthetic mepivacaine; oral buprenorphine (REL-1028) its oral dosage form of the opioid analgesic buprenorphine; and LevoCap ER (REL-1015), its abuse resistant, sustained release dosage form of the opioid analgesic levorphanol. Relmada`s product development efforts are guided by the internationally recognized scientific expertise of our research team. Relmada`s approach is expected to reduce clinical development risks and costs while potentially delivering valuable products in areas of high unmet medical needs.